<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl17" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th>Group 1</th><th>Group 2</th><th>Effect size <italic>d</italic></th><th>A Priori power</th><th>Group 1 sample size</th><th>Group 2 sample size</th></tr></thead><tbody><tr><td>No stromal cells treated with PLX4720 and vehicle</td><td>LL 86 stromal cells treated with PLX4720 and vehicle</td><td>3.369918</td><td>83.8%<xref ref-type="table-fn" rid="tblfn12"><sup>a</sup></xref></td><td>4<xref ref-type="table-fn" rid="tblfn12"><sup>a</sup></xref></td><td>4<xref ref-type="table-fn" rid="tblfn12"><sup>a</sup></xref></td></tr><tr><td>LL 86 stromal cells treated with PLX4720 and vehicle</td><td>LL 86 stromal cells treated with PLX4720 and crizotinib</td><td>3.984418</td><td>94.2%<xref ref-type="table-fn" rid="tblfn13"><sup>b</sup></xref></td><td>4<xref ref-type="table-fn" rid="tblfn13"><sup>b</sup></xref></td><td>4<xref ref-type="table-fn" rid="tblfn13"><sup>b</sup></xref></td></tr><tr><td>LL 86 stromal cells treated with PLX4720 and vehicle</td><td>CCD-1090Sk stromal cells treated with PLX4720 and vehicle</td><td>3.909692</td><td>93.4%<xref ref-type="table-fn" rid="tblfn14"><sup>c</sup></xref></td><td>4<xref ref-type="table-fn" rid="tblfn14"><sup>c</sup></xref></td><td>4<xref ref-type="table-fn" rid="tblfn14"><sup>c</sup></xref></td></tr><tr><td>LL 86 stromal cells treated with PLX4720 and vehicle</td><td>LL 86 stromal cells treated with PLX4720 and PHA-665752</td><td>3.984418</td><td>94.2%<xref ref-type="table-fn" rid="tblfn15"><sup>d</sup></xref></td><td>4<xref ref-type="table-fn" rid="tblfn15"><sup>d</sup></xref></td><td>4<xref ref-type="table-fn" rid="tblfn15"><sup>d</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="tblfn12"><label>a</label><p>6 per group will be used based on the PD184352 planned comparisons making the power 99.1%.</p></fn><fn id="tblfn13"><label>b</label><p>6 per group will be used based on the PD184352 planned comparisons making the power 99.9%.</p></fn><fn id="tblfn14"><label>c</label><p>6 per group will be used based on the PD184352 planned comparisons making the power 99.9%.</p></fn><fn id="tblfn15"><label>d</label><p>6 per group will be used based on the PD184352 planned comparisons making the power 99.9%.</p></fn></table-wrap-foot></table-wrap>